We are live on
!
Find out more
Nicholas Company Portfolio holdings
AUM
$5.47B
Turnover
6.8%
1-Year Est. Return
16.96%
This Fund
S&P 500
This Quarter
Est. Return
+3.67%
1 Year Est. Return
+16.96%
3 Year Est. Return
+65.72%
5 Year Est. Return
+94.16%
10 Year Est. Return
+404.17%
AUM
$4.5B
AUM Growth
+$94.9M
(+2.2%)
Cap. Flow
-$25.6M
Cap. Flow
% of AUM
-0.57%
Top 10 Holdings %
Top 10 Hldgs %
21.03%
Holding
225
New
17
Increased
85
Reduced
77
Closed
10
Avg Time Held
2.2
years
Top 10 Avg Time Held
1.6
years
Top 20 Avg Time Held
1.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fastenal
FAST
|
+$35.3M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$21M |
| 3 |
Keurig Dr Pepper
KDP
|
+$20.3M |
| 4 |
Equifax
EFX
|
+$17.3M |
| 5 |
East-West Bancorp
EWBC
|
+$13.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DaVita
DVA
|
+$42.1M |
| 2 |
W.W. Grainger
GWW
|
+$41.1M |
| 3 |
AbbVie
ABBV
|
+$35.2M |
| 4 |
Skyworks Solutions
SWKS
|
+$25.8M |
| 5 |
PNRA
Panera Bread Co
PNRA
|
+$11.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.03% |
| 2 | Technology | 17.98% |
| 3 | Financials | 15.03% |
| 4 | Industrials | 14.79% |
| 5 | Consumer Discretionary | 13.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
201
Burlington
BURL
$16.8B
| $1.86M | 0.04% |
20,255
-15,740
| -44% | -$1.51M |
2016 Q1
5 quarters
|
|
|
CONE
202
DELISTED
CyrusOne Inc Common Stock
CONE
| $1.79M | 0.04% |
+32,085
| New | +$1.77M |
2017 Q2
0 quarters
|
|
203
T. Rowe Price
TROW
$21.6B
| $1.33M | 0.03% |
18,000
| – | – |
2013 Q2
16 quarters
|
|
204
Chevron
CVX
$430B
| $1.3M | 0.03% |
12,470
| – | – |
2013 Q2
16 quarters
|
|
205
Universal Health Services
UHS
$11B
| $927K | 0.02% |
7,600
-65,365
| -90% | -$7.78M |
2014 Q1
13 quarters
|
|
206
Marsh
MRSH
$89B
| $904K | 0.02% |
11,600
| – | – |
2013 Q2
16 quarters
|
|
207
Dollar General
DG
$29.5B
| $699K | 0.02% |
9,700
-4,900
| -34% | -$353K |
2015 Q4
6 quarters
|
|
208
PepsiCo
PEP
$175B
| $612K | 0.01% |
5,300
| – | – |
2013 Q2
16 quarters
|
|
209
C.H. Robinson
CHRW
$16.8B
| $611K | 0.01% |
8,900
-101,770
| -92% | -$7.21M |
2016 Q1
5 quarters
|
|
210
DELISTED
Coresite Realty Corporation
COR
| $569K | 0.01% |
+5,500
| New | +$552K |
2017 Q2
0 quarters
|
|
|
211
W.W. Grainger
GWW
$62.7B
| $568K | 0.01% |
3,150
-217,840
| -99% | -$41.1M |
2013 Q2
16 quarters
|
|
212
BlackLine
BL
$1.77B
| $290K | 0.01% |
+8,115
| New | +$269K |
2017 Q2
0 quarters
|
|
213
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $214K | ﹤0.01% |
12,200
-1,000
| -8% | -$17.8K |
2013 Q4
14 quarters
|
|
|
214
AbbVie
ABBV
$501B
| – | – |
-540,620
| Closed | -$35.2M | – |
|
215
Community Bank
CBU
$3.14B
| – | – |
-4,800
| Closed | -$263K | – |
|
216
Gentex
GNTX
$4.45B
| – | – |
-428,380
| Closed | -$9.14M | – |
|
217
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$5.84B
| – | – |
-4,167
| Closed | -$461K | – |
|
218
McDonald's
MCD
$172B
| – | – |
-600
| Closed | -$77K | – |
|
219
WPP
WPP
$5.86B
| – | – |
-101,640
| Closed | -$11.1M | – |
|
220
Williams-Sonoma
WSM
$29.7B
| – | – |
-6,200
| Closed | -$166K | – |
|
|
ALXN
221
DELISTED
Alexion Pharmaceuticals
ALXN
| – | – |
-50,265
| Closed | -$6.09M | – |
|
|
WSTC
222
DELISTED
West Corporation
WSTC
| – | – |
-19,800
| Closed | -$483K | – |
|
|
PNRA
223
DELISTED
Panera Bread Co
PNRA
| – | – |
-45,280
| Closed | -$11.9M | – |
|
Similar funds
SCM
Nicholas Company's Q2 2017 Portfolio in Review
As of Q2 2017, Nicholas Company held 225 positions worth $4.5B, up 2.2% from $4.4B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Nicholas Company's Q2 2017 filing shows 17 new, 85 increased, 77 reduced and 10 closed positions. Its largest new stake was Keurig Dr Pepper: 216,925 shares worth $19.8M. The largest sale was DaVita, an estimated $42.1M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Technology and Financials.
- Nicholas Company's largest Q2 2017 buy was Keurig Dr Pepper: 216,925 shares worth $19.8M.
- Nicholas Company added most to Fastenal in Q2 2017, an estimated $35.3M increase.
- Nicholas Company's biggest Q2 2017 reduction was DaVita, cutting an estimated $42.1M.
- Nicholas Company fully exited AbbVie in Q2 2017, selling an estimated $35.2M.
- Nicholas Company's ten largest holdings make up 21% of its $4.5B portfolio in Q2 2017.
- Nicholas Company opened 17 new positions and closed 10 in Q2 2017.
- Nicholas Company's portfolio value rose 2.2% quarter-over-quarter to $4.5B.
Based on Nicholas Company's 13F filing for Q2 2017, filed 11 Aug 2017.